Literature DB >> 33097441

G6PD: A hub for metabolic reprogramming and redox signaling in cancer.

Hung-Chi Yang1, Arnold Stern2, Daniel Tsun-Yee Chiu3.   

Abstract

Metabolic hubs play a major role in the initiation and development of cancer. Oncogenic signaling pathways drive metabolic reprogramming and alter redox homeostasis. G6PD has potential oncogenic activity and it plays a pivotal role in cell proliferation, survival and stress responses. Aberrant activation of G6PD via metabolic reprogramming alters NADPH levels, leading to an antioxidant or a pro-oxidant environment which can either enhance DNA oxidative damage and genomic instability or initiate oncogenic signaling. Nutrient deprivation can rewire metabolism, which leads to mutations that determine a cancer cell's fate. Deregulated G6PD status and oxidative stress form a vicious cycle, which paves the way for cancer progression. This review aims to update and focus the potential role of G6PD in metabolic reprogramming and redox signaling in cancer.
Copyright © 2021 Chang Gung University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; G6PD; Metabolic reprogramming; Oncogene; Oxidative stress; Redox

Year:  2020        PMID: 33097441     DOI: 10.1016/j.bj.2020.08.001

Source DB:  PubMed          Journal:  Biomed J        ISSN: 2319-4170            Impact factor:   4.910


  8 in total

1.  Transcription Factor NRF2 Participates in Cell Cycle Progression at the Level of G1/S and Mitotic Checkpoints.

Authors:  Diego Lastra; Maribel Escoll; Antonio Cuadrado
Journal:  Antioxidants (Basel)       Date:  2022-05-11

2.  The Transcription Coregulator RIP140 Inhibits Cancer Cell Proliferation by Targeting the Pentose Phosphate Pathway.

Authors:  Valentin Jacquier; Delphine Gitenay; Vincent Cavaillès; Catherine Teyssier
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

3.  Identification of Metabolic-Associated Genes for the Prediction of Colon and Rectal Adenocarcinoma.

Authors:  Yanfen Cui; Baoai Han; He Zhang; Hui Liu; Fei Zhang; Ruifang Niu
Journal:  Onco Targets Ther       Date:  2021-03-31       Impact factor: 4.147

4.  Proteomic Landscape of Extracellular Vesicles for Diffuse Large B-Cell Lymphoma Subtyping.

Authors:  Ana Sofia Carvalho; Henrique Baeta; Andreia F A Henriques; Mostafa Ejtehadifar; Erin M Tranfield; Ana Laura Sousa; Ana Farinho; Bruno Costa Silva; José Cabeçadas; Paula Gameiro; Maria Gomes da Silva; Hans Christian Beck; Rune Matthiesen
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

Review 5.  The Multiple Roles of Glucose-6-Phosphate Dehydrogenase in Tumorigenesis and Cancer Chemoresistance.

Authors:  Jiaqi Song; Huanran Sun; Shuai Zhang; Changliang Shan
Journal:  Life (Basel)       Date:  2022-02-12

6.  Effect of pH on the structure and function of cyclin-dependent kinase 6.

Authors:  Mohd Yousuf; Anas Shamsi; Farah Anjum; Alaa Shafie; Asimul Islam; Qazi Mohd Rizwanul Haque; Abdelbaset Mohamed Elasbali; Dharmendra Kumar Yadav; Md Imtaiyaz Hassan
Journal:  PLoS One       Date:  2022-02-11       Impact factor: 3.240

Review 7.  Tumor Glucose and Fatty Acid Metabolism in the Context of Anthracycline and Taxane-Based (Neo)Adjuvant Chemotherapy in Breast Carcinomas.

Authors:  Anna Mária Tőkés; Stefan Vári-Kakas; Janina Kulka; Beáta Törőcsik
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

8.  Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy.

Authors:  Lihua Yu; Xiaoli Liu; Xinhui Wang; Huiwen Yan; Qing Pu; Yuqing Xie; Juan Du; Zhiyun Yang
Journal:  Front Cell Dev Biol       Date:  2022-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.